$GEVO

Bowron Kimberly T sold $44K of GEVO

Bowron Kimberly T (Chief of Staff) sold 25,101 shares of Gevo, Inc. (GEVO) at $1.76 on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bowron Kimberly T
Published May 29, 2026, 9:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 9:39 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The market may interpret the sale as mild negative sentiment, but without accompanying company-specific fundamentals, it is unlikely to drive a sustained repricing.

02

Market read

A single insider sale in a pre-planned program is usually a low-signal event; traders may use it as a minor sentiment check.

03

What to watch

The disclosure does not indicate whether the insider also bought shares later, nor does it reveal broader company performance changes around the same period.

Relevance 6/10Novelty 6/10Timing: Filed May 29, covering a sale executed May 27

Background

This is an SEC Form 4 insider transaction: an officer (Chief of Staff) reported an open-market sale under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Gevo insider Chief of Staff Bowron Kimberly T sold 25,101 shares in an open-market transaction disclosed on Form 4.

Expected impact

Likely limited/short-lived impact; any move would be small unless paired with other news.

Evidence & confidence

The filing is an ownership-change disclosure with no new operational or financial information; it may slightly influence sentiment, especially for thinly traded names.

Market effects

For speculative biofuels/renewables names, insider selling can reinforce caution but typically does not reset sector expectations without additional catalysts.

None indicated beyond company-specific sentiment.

None indicated.

Counterpoint

Because the sale was under a pre-arranged Rule 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Gevo, Inc.

    Subject of the insider transaction disclosure (Form 4).

  • Bowron Kimberly T

    Chief of Staff who sold 25,101 shares on May 27 under a 10b5-1 plan.

Related articles

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gevo_q2x2026-ex991.htm EX-99.1 Document Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, tod

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.

$GEVOMed

Gevo Provides Business Update and Announces Progress on Business Objectives

Gevo, Inc. (NASDAQ: GEVO) reported progress on its 2026 business objectives, aiming to potentially more than double prior estimates for non-GAAP Adjusted EBITDA by unlocking carbon pathways, debottlenecking operations, and cost improvements. It expects CFR credit sales in Q3 2026, targets over $70M in 2026 Section 45Z tax credit monetizations, and is advancing Gevo North Dakota expansion and Project Northstar. Q2 results are due Aug. 6.